Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus
about
Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageSpecific complex of human immunodeficiency virus type 1 rev and nucleolar B23 proteins: dissociation by the Rev response elementPathogenesis of human immunodeficiency virus infectionHuman immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAsRegulation of human immunodeficiency virus env expression by the rev gene productSubcellular localization of the human immunodeficiency virus trans-acting art gene productHeterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to functionThe basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assemblyEukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activationCortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaineRole of RNA helicases in HIV-1 replicationReal-time kinetics of HIV-1 Rev-Rev response element interactions. Definition of minimal binding sites on RNA and protein and stoichiometric analysisA novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteinsIn vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNAInhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotidesRequirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusionA long-awaited structure is rev-ealed.Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export.Single-nucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev functionThe human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments.Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intronAvian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasmNuclear interactions are necessary for translational enhancement by spleen necrosis virus RU5.Retroviruses and cancer: models for cancer in animals and humans.Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation.cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K.Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy.Trans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA.Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I.Control of human immunodeficiency virus type 1 RNA metabolism: role of splice sites and intron sequences in unspliced viral RNA subcellular distribution.Purification and characterization of recombinant Rev protein of human immunodeficiency virus type 1.U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced.Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expressionConstruction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme.Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-Intronless mRNA transport elements may affect multiple steps of pre-mRNA processing.A tripartite HIV-1 tat-env-rev fusion protein
P2860
Q24531468-F996C1D4-4BDA-4DAC-938E-2BB2190255A1Q24603188-A04752F4-5681-425E-A121-46657CEDE29AQ24634681-E5390CF2-E9E0-49C0-9FB5-270B4A758765Q24645943-72E8414D-21CE-4A64-8E8B-A9FD6F622DD9Q24646216-F4EA6952-37C6-424B-8A51-357FD953BC7AQ24651489-81F21226-4267-4FAB-93BE-6EC512174ACCQ24652351-6D8369C2-8277-47FC-8CB7-76F19ABB303BQ24652587-35139CB0-277C-44E9-A66D-4C32B73E7B7DQ24656044-F06BB902-5C99-4ED0-B6F1-D3A02DEE4E32Q24657633-4BC9C06E-2132-42C0-A5C1-517C1E21738FQ27013928-01A305BD-277C-45C7-9332-065250B17D3FQ27477537-616180A1-9C17-41B8-9A62-54D88DFA5760Q28199340-DB0C68D6-6819-4694-9F27-B58DAF97417AQ28246228-7F0BDB4A-F2B9-40F1-B5A7-3DB947386D00Q28278287-424B3FD5-FB6E-4C61-848B-D03FDB35D338Q28279513-8E147F6D-5EF3-4D6F-95B5-79F12766FBEAQ28324342-61E837C7-75E5-4047-9348-B04F5C21C03AQ28646837-5BF1F277-5853-4A98-BE05-87B03FD6C0EFQ30407389-C2A6A157-B1C9-4DBB-B623-F921E1A39381Q30413069-D0D58740-09DC-4DEF-A858-15EF2A60221EQ30430496-AC87B04A-A6F3-431A-8DE2-09402FAF28E3Q30450201-F3E7763B-72B0-4D25-A8BD-B966169290E6Q30450216-7BBAAB3D-2572-4AB2-94B9-F9FC17C4A262Q30452134-5977FF6B-C8A1-42AE-A8A5-EC827EAE105AQ30452592-1AA4CA34-E8CF-4683-BB7B-B753FCF78730Q30453281-E5323B06-A31A-40BA-8338-F3FB3644FF9BQ30467457-F0FE14AF-0179-4D6F-A9B7-7A3DA3443423Q33282047-A9C171DB-80F6-4F2D-A917-1C037A35B876Q33292473-D418A112-14F3-4B90-8044-053A7B6E7F20Q33541775-9ABF7BB5-9E6F-43DE-828D-69A1F4635BC4Q33634797-5C8FD915-AAEE-4158-A518-920E257003A4Q33650651-A627D840-9CA5-4403-BF37-B4B887CBF2E8Q33785931-51758077-C879-49CB-8E76-F769E8325A7AQ33821408-2EF10C0B-40AC-418A-9C40-F3FFF8DF823BQ33821654-CF72C51D-B0DC-468E-A5C1-44E16B277D94Q33851952-897CB414-2B38-4DD3-9B52-C3B88C9479A0Q33859324-DE5C9143-40C1-4A6B-8728-35F45A645D3EQ33866139-50CE2E57-599A-4FFB-A72E-5BFB24800B8CQ33890618-01F5955D-738B-4927-866B-9B3260E6BEC6Q33918908-E2B117D1-567C-4BBB-859F-BFE9C3BF5430
P2860
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus
description
1988 nî lūn-bûn
@nan
1988 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus
@ast
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus
@en
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.
@nl
type
label
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus
@ast
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus
@en
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.
@nl
prefLabel
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus
@ast
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus
@en
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.
@nl
P2093
P2860
P356
P1476
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus
@en
P2093
E Terwilliger
J G Sodroski
P2860
P304
P356
10.1073/PNAS.85.7.2071
P407
P577
1988-04-01T00:00:00Z